Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in COPD Exacerbation and Pulmonary Hypertension
NCT04538976Phase 4Completed
- Sponsor
- COPD360Net
- Start
- Feb 2020
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sildenafil in pulmonary hypertension (PH), sponsored by COPD360Net. Started Feb 2020; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04538976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04538976.